A smarter approach is to continue probiotics throughout your semaglutide treatment, including through all dose titrations
Estimate whether heat or freezing occurred
Studies have shown that Semaglutide treatment resulted in significant, lasting weight loss over 104 weeks compared to a placebo
GLP-1 receptor agonists, including semaglutide, liraglutide and dulaglutide, increase glucose-dependent insulin release, reduce appetite and slow stomach emptying
[11] In April 2026 the sponsor announced that SYNCHRONIZE-1 a double-blind, placebo-controlled study of roughly 725 adults with obesity or overweight without diabetes met its co-primary endpoints, reporting mean bodyweight loss of about 16.6% at 76 weeks versus about 3.2% on placebo, with a large proportion of participants achieving at least 5% weight loss
Ready to explore a personalized, effective path to weight loss